References
1. World Health Organization. Consolidated guideline on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd ed. Geneva: World Health Organization; 2016. p.91-154. 2. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015. p.24-53. 3. Kementerian Kesehatan Republik Indonesia. Pedoman pengobatan antiretroviral. Jakarta: Kementerian Kesehatan Republik Indonesia; 2015. 4. Dybul M, FauciAS, Bartlett JG, Kaplan JE, Pau AK, et al. Panel on Clinical Practices for the Treatment of HIV. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the panel on clinical practices for treatment of HIV. Ann Intern Med. 2002;137(5 Pt 2):381-433. 5. Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64:74–8. 6. Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas J-P, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22:289–99. 7. Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13:459–64. 8. Haubrich, RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13(9):1099-107. 9. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171-6. 10. Kelley CF, Kitchen CM, Hunt PW, Rodriguez B, Hecht FM, Kitahata M, et al. Incomplete peripheral CD4+ cell count restoration in HIVinfected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48(6):787-94. 11. Greub G, Ledergerber B, Battegay M, Grop P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356(9244):1800-5. 12. Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, et al; ACTG 384 team. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006;42(4):426-34. 13. Kurniawan F, Djauzi S, Yunihastuti E, Nugroho P. Faktor prediktor kegagalan virologis pada pasien HIV yang mendapat terapi ARV lini pertama dengan kepatuhan berobat baik. JPDI. 2017;4(1):30–4.
Recommended Citation
Karyadi, Teguh H.
(2017)
"Keberhasilan Pengobatan Antiretroviral (ARV),"
Jurnal Penyakit Dalam Indonesia: Vol. 4:
Iss.
1, Article 1.
DOI: 10.7454/jpdi.v4i1.105
Available at:
https://scholarhub.ui.ac.id/jpdi/vol4/iss1/1
